vs
OOMA INC（OOMA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是OOMA INC的1.1倍（$75.5M vs $67.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.8%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $5.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 4.7%）
Ooma Inc是一家总部位于美国加利福尼亚州硅谷的上市电信企业，面向家庭、企业以及移动用户提供包含VoIP网络电话在内的各类通讯服务，在电信服务领域拥有成熟的业务布局。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
OOMA vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$67.6M
营收增速更快
PBYI
高出23.9%
3.8%
自由现金流更多
PBYI
多$8.9M
$5.4M
两年增速更快
PBYI
近两年复合增速
4.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.6M | $75.5M |
| 净利润 | $1.4M | — |
| 毛利率 | 60.2% | 69.3% |
| 营业利润率 | 1.9% | 22.7% |
| 净利率 | 2.1% | — |
| 营收同比 | 3.8% | 27.7% |
| 净利润同比 | 158.9% | — |
| 每股收益（稀释后） | $0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OOMAPBYI
| Q4 25 | $67.6M | $75.5M | ||
| Q3 25 | $66.4M | $54.5M | ||
| Q2 25 | $65.0M | $52.4M | ||
| Q1 25 | $65.1M | $46.0M | ||
| Q4 24 | $65.1M | $59.1M | ||
| Q3 24 | $64.1M | $80.5M | ||
| Q2 24 | $62.5M | $47.1M | ||
| Q1 24 | $61.7M | $43.8M |
净利润OOMAPBYI
| Q4 25 | $1.4M | — | ||
| Q3 25 | $1.3M | $8.8M | ||
| Q2 25 | $-141.0K | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $-2.1M | $20.3M | ||
| Q2 24 | $-2.1M | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率OOMAPBYI
| Q4 25 | 60.2% | 69.3% | ||
| Q3 25 | 60.6% | 77.7% | ||
| Q2 25 | 61.8% | 76.5% | ||
| Q1 25 | 61.3% | 77.1% | ||
| Q4 24 | 60.3% | 76.4% | ||
| Q3 24 | 60.3% | 63.9% | ||
| Q2 24 | 61.0% | 77.4% | ||
| Q1 24 | 61.2% | 75.5% |
营业利润率OOMAPBYI
| Q4 25 | 1.9% | 22.7% | ||
| Q3 25 | 1.4% | 17.6% | ||
| Q2 25 | -0.1% | 12.7% | ||
| Q1 25 | -0.5% | 8.7% | ||
| Q4 24 | -3.5% | 22.6% | ||
| Q3 24 | -2.5% | 27.4% | ||
| Q2 24 | -4.4% | -4.6% | ||
| Q1 24 | -3.9% | -5.3% |
净利率OOMAPBYI
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.9% | 16.2% | ||
| Q2 25 | -0.2% | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | -3.6% | — | ||
| Q3 24 | -3.3% | 25.2% | ||
| Q2 24 | -3.4% | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）OOMAPBYI
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $0.04 | $0.17 | ||
| Q2 25 | $-0.01 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $-0.09 | $0.40 | ||
| Q3 24 | $-0.08 | $0.41 | ||
| Q2 24 | $-0.08 | $-0.09 | ||
| Q1 24 | $-0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $90.0M | $130.3M |
| 总资产 | $152.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资OOMAPBYI
| Q4 25 | $21.7M | $97.5M | ||
| Q3 25 | $19.6M | $94.4M | ||
| Q2 25 | $19.0M | $96.0M | ||
| Q1 25 | $17.9M | $93.2M | ||
| Q4 24 | $17.1M | $101.0M | ||
| Q3 24 | $16.6M | $96.7M | ||
| Q2 24 | $15.6M | $96.8M | ||
| Q1 24 | $17.5M | $107.2M |
总债务OOMAPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | $0 | $56.7M | ||
| Q4 24 | $3.0M | $68.0M | ||
| Q3 24 | $8.5M | $79.3M | ||
| Q2 24 | $11.5M | $90.7M | ||
| Q1 24 | $16.0M | $102.0M |
股东权益OOMAPBYI
| Q4 25 | $90.0M | $130.3M | ||
| Q3 25 | $88.1M | $115.3M | ||
| Q2 25 | $87.7M | $104.7M | ||
| Q1 25 | $85.3M | $97.1M | ||
| Q4 24 | $83.5M | $92.1M | ||
| Q3 24 | $81.8M | $71.1M | ||
| Q2 24 | $81.0M | $48.5M | ||
| Q1 24 | $78.1M | $51.0M |
总资产OOMAPBYI
| Q4 25 | $152.7M | $216.3M | ||
| Q3 25 | $150.1M | $202.9M | ||
| Q2 25 | $148.8M | $194.9M | ||
| Q1 25 | $149.2M | $196.2M | ||
| Q4 24 | $149.6M | $213.3M | ||
| Q3 24 | $151.5M | $220.7M | ||
| Q2 24 | $155.2M | $205.0M | ||
| Q1 24 | $159.3M | $214.1M |
负债/权益比OOMAPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | 0.00× | 0.58× | ||
| Q4 24 | 0.04× | 0.74× | ||
| Q3 24 | 0.10× | 1.12× | ||
| Q2 24 | 0.14× | 1.87× | ||
| Q1 24 | 0.20× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 8.1% | 19.1% |
| 资本支出强度资本支出/营收 | 2.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.97× | — |
| 过去12个月自由现金流最近4个季度 | $19.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流OOMAPBYI
| Q4 25 | $6.9M | $14.4M | ||
| Q3 25 | $6.4M | $9.7M | ||
| Q2 25 | $3.7M | $14.1M | ||
| Q1 25 | $7.8M | $3.6M | ||
| Q4 24 | $8.1M | $15.6M | ||
| Q3 24 | $7.1M | $11.0M | ||
| Q2 24 | $3.6M | $1.0M | ||
| Q1 24 | $5.5M | $11.2M |
自由现金流OOMAPBYI
| Q4 25 | $5.4M | $14.4M | ||
| Q3 25 | $5.0M | $9.7M | ||
| Q2 25 | $2.5M | $14.1M | ||
| Q1 25 | $6.1M | $3.6M | ||
| Q4 24 | $6.5M | $15.6M | ||
| Q3 24 | $5.3M | $11.0M | ||
| Q2 24 | $2.1M | $1.0M | ||
| Q1 24 | $4.2M | — |
自由现金流率OOMAPBYI
| Q4 25 | 8.1% | 19.1% | ||
| Q3 25 | 7.6% | 17.7% | ||
| Q2 25 | 3.8% | 26.8% | ||
| Q1 25 | 9.4% | 7.7% | ||
| Q4 24 | 10.0% | 26.4% | ||
| Q3 24 | 8.3% | 13.7% | ||
| Q2 24 | 3.4% | 2.1% | ||
| Q1 24 | 6.9% | — |
资本支出强度OOMAPBYI
| Q4 25 | 2.2% | 0.0% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 1.9% | 0.0% | ||
| Q1 25 | 2.6% | 0.1% | ||
| Q4 24 | 2.4% | 0.0% | ||
| Q3 24 | 2.7% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 2.1% | 0.0% |
现金转化率OOMAPBYI
| Q4 25 | 4.97× | — | ||
| Q3 25 | 5.07× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OOMA
| Subscription And Services Revenue | $62.0M | 92% |
| Product And Other Revenue | $5.7M | 8% |
PBYI
暂无分部数据
